Devroe Eric — SEC insider filings
SEC reporting owner CIK 1950573. 21 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2022-11-16 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $17,218 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 1,232 shares, $2,125 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 10,000 shares @ $1.72 ($17,218) in Acrivon Therapeutics, Inc., filed 2026-01-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | 21 | 1 leg · 10,000 sh · $17,218 | 2 legs · 1,232 sh · $2,125 | 21 |
Insider filings — Devroe Eric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Sale (S): 628 @ $1.45 | EDGAR |
| 2026-08-20 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Sale (S): 604 @ $2.01 | EDGAR |
| 2026-05-20 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 72,981 @ $0 | EDGAR |
| 2026-05-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $1.92 | EDGAR |
| 2026-03-03 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 186,728 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 723 @ $1.63 | EDGAR |
| 2026-01-15 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Purchase (P): 10,000 @ $1.72 | EDGAR |
| 2025-11-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $2.24 | EDGAR |
| 2025-08-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $1.39 | EDGAR |
| 2025-05-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $1.14 | EDGAR |
| 2025-03-04 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 140,540 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 724 @ $5.42 | EDGAR |
| 2024-11-27 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 90,090 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $7.92 | EDGAR |
| 2024-08-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $7.02 | EDGAR |
| 2024-05-21 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Option exercise (M): 10,000 @ $1.04 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 613 @ $8.36 | EDGAR |
| 2024-02-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 723 @ $3.40 | EDGAR |
| 2023-11-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Tax withholding (F): 2,450 @ $5.08 | EDGAR |
| 2023-06-06 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Option exercise (M): 9,225 @ $1.04 · Option exercise (M): 9,225 (derivative) @ $0 | EDGAR |
| 2022-11-16 | 4 | Acrivon Therapeutics, Inc. (ACRV) | Grant/award (A): 33,383 @ $0 · Grant/award (A): 100,150 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1950573 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs